![HEI HEI](https://data.pdbj.org/pdbjplus/data/cc/svg/HEI.svg) | HEI | Name: | 1-(2-{3-[(2,4-diamino-6-ethylpyrimidin-5-yl)oxy]propoxy}phenyl)piperidine-4-carboxylic acid | Formula: | C21 H29 N5 O4 | SMILES: | CCc1nc(N)nc(N)c1OCCCOc1ccccc1N1CCC(CC1)C(=O)O | InChi: | InChI=1S/C21H29N5O4/c1-2-15-18(19(22)25-21(23)24-15)30-13-5-12-29-17-7-4-3-6-16(17)26-10-8-14(9-11-26)20(27)28/h3-4,6-7,14H,2,5,8-13H2,1H3,(H,27,28)(H4,22,23,24,25) | Definition date: | 2022-01-03 | Last modified: | 2022-02-04 | Release date: | 2022-02-09 | Identifier: | 1-(2-{3-[(2,4-diamino-6-ethylpyrimidin-5-yl)oxy]propoxy}phenyl)piperidine-4-carboxylic acid |
|
![8VD 8VD](https://data.pdbj.org/pdbjplus/data/cc/svg/8VD.svg) | 8VD | Name: | N-(piperidin-4-yl)-6-(trifluoromethyl)pyrimidin-4-amine | Formula: | C10 H13 F3 N4 | SMILES: | FC(F)(F)c1cc(ncn1)NC1CCNCC1 | InChi: | InChI=1S/C10H13F3N4/c11-10(12,13)8-5-9(16-6-15-8)17-7-1-3-14-4-2-7/h5-7,14H,1-4H2,(H,15,16,17) | Definition date: | 2021-10-01 | Last modified: | 2022-02-04 | Release date: | 2022-02-09 | Identifier: | N-(piperidin-4-yl)-6-(trifluoromethyl)pyrimidin-4-amine |
|
![8W1 8W1](https://data.pdbj.org/pdbjplus/data/cc/svg/8W1.svg) | 8W1 | Name: | (5S)-3-methyl-7-(trifluoromethyl)pyrrolo[1,2-a]pyrazin-1(2H)-one | Formula: | C9 H7 F3 N2 O | SMILES: | FC(F)(F)c1cn2C=C(C)NC(=O)c2c1 | InChi: | InChI=1S/C9H7F3N2O/c1-5-3-14-4-6(9(10,11)12)2-7(14)8(15)13-5/h2-4H,1H3,(H,13,15) | Definition date: | 2021-10-01 | Last modified: | 2022-02-04 | Release date: | 2022-02-09 | Identifier: | (5S)-3-methyl-7-(trifluoromethyl)pyrrolo[1,2-a]pyrazin-1(2H)-one |
|
![8WP 8WP](https://data.pdbj.org/pdbjplus/data/cc/svg/8WP.svg) | 8WP | Name: | 2-[(8S)-4-oxo-2-(trifluoromethyl)-4,5-dihydropyrazolo[1,5-a]pyrazin-6-yl]acetamide | Formula: | C9 H7 F3 N4 O2 | SMILES: | NC(=O)CC1=Cn2nc(cc2C(=O)N1)C(F)(F)F | InChi: | InChI=1S/C9H7F3N4O2/c10-9(11,12)6-2-5-8(18)14-4(1-7(13)17)3-16(5)15-6/h2-3H,1H2,(H2,13,17)(H,14,18) | Definition date: | 2021-10-01 | Last modified: | 2022-02-04 | Release date: | 2022-02-09 | Identifier: | 2-[(8S)-4-oxo-2-(trifluoromethyl)-4,5-dihydropyrazolo[1,5-a]pyrazin-6-yl]acetamide |
|
![8XF 8XF](https://data.pdbj.org/pdbjplus/data/cc/svg/8XF.svg) | 8XF | Name: | 6-(trifluoromethyl)pyrimidin-4-amine | Formula: | C5 H4 F3 N3 | SMILES: | Nc1cc(ncn1)C(F)(F)F | InChi: | InChI=1S/C5H4F3N3/c6-5(7,8)3-1-4(9)11-2-10-3/h1-2H,(H2,9,10,11) | Definition date: | 2021-10-01 | Last modified: | 2022-02-04 | Release date: | 2022-02-09 | Identifier: | 6-(trifluoromethyl)pyrimidin-4-amine |
|
![V1W V1W](https://data.pdbj.org/pdbjplus/data/cc/svg/V1W.svg) | V1W | Name: | v-coelenterazine | Formula: | C28 H21 N3 O5 | SMILES: | OO[C]1(Cc2ccc(O)cc2)N=C3N(C1=O)c4ccc5cc(O)ccc5c4N=C3Cc6ccccc6 | InChi: | InChI=1S/C28H21N3O5/c32-20-9-6-18(7-10-20)16-28(36-35)27(34)31-24-13-8-19-15-21(33)11-12-22(19)25(24)29-23(26(31)30-28)14-17-4-2-1-3-5-17/h1-13,15,32-33,35H,14,16H2/t28-/m0/s1 | Definition date: | 2021-04-06 | Last modified: | 2022-02-04 | Release date: | 2022-02-09 |
|
![VFD VFD](https://data.pdbj.org/pdbjplus/data/cc/svg/VFD.svg) | VFD | Name: | Olodanrigan | Formula: | C32 H29 N O5 | SMILES: | N3(C(=O)C(c1ccccc1)c2ccccc2)Cc4c(CC3C(O)=O)c(c(cc4)OC)OCc5ccccc5 | InChi: | InChI=1S/C32H29NO5/c1-37-28-18-17-25-20-33(31(34)29(23-13-7-3-8-14-23)24-15-9-4-10-16-24)27(32(35)36)19-26(25)30(28)38-21-22-11-5-2-6-12-22/h2-18,27,29H,19-21H2,1H3,(H,35,36)/t27-/m0/s1 | Synonyms: | EMA401 | Definition date: | 2020-08-06 | Last modified: | 2022-02-04 | Release date: | 2022-02-09 | Identifier: | (3S)-5-(benzyloxy)-2-(diphenylacetyl)-6-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid |
|
![VJH VJH](https://data.pdbj.org/pdbjplus/data/cc/svg/VJH.svg) | VJH | Name: | 2-[4-[[4-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]-6-[(3-methyl-1~{H}-pyrazol-5-yl)amino]pyrimidin-2-yl]amino]phenyl]-~{N}-(3-fluorophenyl)ethanamide | Formula: | C29 H31 F N10 O | SMILES: | CN(C)CCn1cc(cn1)c2cc(Nc3[nH]nc(C)c3)nc(Nc4ccc(CC(=O)Nc5cccc(F)c5)cc4)n2 | InChi: | InChI=1S/C29H31FN10O/c1-19-13-27(38-37-19)35-26-16-25(21-17-31-40(18-21)12-11-39(2)3)34-29(36-26)33-23-9-7-20(8-10-23)14-28(41)32-24-6-4-5-22(30)15-24/h4-10,13,15-18H,11-12,14H2,1-3H3,(H,32,41)(H3,33,34,35,36,37,38) | Definition date: | 2021-05-19 | Last modified: | 2022-02-04 | Release date: | 2022-02-09 | Identifier: | 2-[4-[[4-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]-6-[(3-methyl-1~{H}-pyrazol-5-yl)amino]pyrimidin-2-yl]amino]phenyl]-~{N}-(3-fluorophenyl)ethanamide |
|
![T0P T0P](https://data.pdbj.org/pdbjplus/data/cc/svg/T0P.svg) | T0P | Name: | [(2~{R},3~{R},4~{S},5~{R})-5-(2-azanyl-6-oxidanylidene-7-phenacyl-1~{H}-purin-9-yl)-4-fluoranyl-3-oxidanyl-oxolan-2-yl]methyl dihydrogen phosphate | Formula: | C18 H20 F N5 O8 P | SMILES: | NC1=Nc2c(n(CC(=O)c3ccccc3)c[n]2[CH]4O[CH](CO[P](O)(O)=O)[CH](O)[CH]4F)C(=O)N1 | InChi: | InChI=1S/C18H20FN5O8P/c19-12-14(26)11(7-31-33(28,29)30)32-17(12)24-8-23(6-10(25)9-4-2-1-3-5-9)13-15(24)21-18(20)22-16(13)27/h1-5,8,11-12,14,17,26H,6-7H2,(H2,28,29,30)(H3,20,21,22,27)/t11-,12+,14-,17-/m1/s1 | Definition date: | 2020-03-16 | Last modified: | 2022-02-04 | Release date: | 2022-02-09 | Identifier: | [(2~{R},3~{R},4~{S},5~{R})-5-(2-azanyl-6-oxidanylidene-7-phenacyl-1~{H}-purin-9-yl)-4-fluoranyl-3-oxidanyl-oxolan-2-yl]methyl dihydrogen phosphate |
|
![WTP WTP](https://data.pdbj.org/pdbjplus/data/cc/svg/WTP.svg) | WTP | Name: | 5-chloro-N~2~-[4-(4-methylpiperazin-1-yl)phenyl]-N~4~-{[(2R)-oxolan-2-yl]methyl}pyrimidine-2,4-diamine | Formula: | C20 H27 Cl N6 O | SMILES: | c1(nc(ncc1Cl)Nc3ccc(N2CCN(C)CC2)cc3)NCC4OCCC4 | InChi: | InChI=1S/C20H27ClN6O/c1-26-8-10-27(11-9-26)16-6-4-15(5-7-16)24-20-23-14-18(21)19(25-20)22-13-17-3-2-12-28-17/h4-7,14,17H,2-3,8-13H2,1H3,(H2,22,23,24,25)/t17-/m1/s1 | Definition date: | 2020-11-11 | Last modified: | 2022-02-04 | Release date: | 2022-02-09 | Identifier: | 5-chloro-N~2~-[4-(4-methylpiperazin-1-yl)phenyl]-N~4~-{[(2R)-oxolan-2-yl]methyl}pyrimidine-2,4-diamine |
|
![X5D X5D](https://data.pdbj.org/pdbjplus/data/cc/svg/X5D.svg) | X5D | Name: | (2R,5R,7R,8R,10S,12aR,14R,15aS,16R)-7-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-2,10,16-trihydroxy-14-[(pyrimidin-4-yl)oxy]decahydro-2H,10H-5,8-methano-2lambda~5~,10lambda~5~-cyclopenta[l][1,3,6,9,11,2,10]pentaoxadiphosphacyclotetradecine-2,10-dione | Formula: | C20 H25 N7 O12 P2 | SMILES: | c1nc6c(n1C5C3C(C(COP(O)(OC2CC(CC2COP(=O)(O3)O)Oc4ncncc4)=O)O5)O)N=C(NC6=O)N | InChi: | InChI=1S/C20H25N7O12P2/c21-20-25-17-14(18(29)26-20)24-8-27(17)19-16-15(28)12(37-19)6-35-40(30,31)38-11-4-10(36-13-1-2-22-7-23-13)3-9(11)5-34-41(32,33)39-16/h1-2,7-12,15-16,19,28H,3-6H2,(H,30,31)(H,32,33)(H3,21,25,26,29)/t9-,10-,11+,12-,15-,16-,19-/m1/s1 | Definition date: | 2020-11-30 | Last modified: | 2022-02-04 | Release date: | 2022-02-09 | Identifier: | (2R,5R,7R,8R,10S,12aR,14R,15aS,16R)-7-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-2,10,16-trihydroxy-14-[(pyrimidin-4-yl)oxy]decahydro-2H,10H-5,8-methano-2lambda~5~,10lambda~5~-cyclopenta[l][1,3,6,9,11,2,10]pentaoxadiphosphacyclotetradecine-2,10-dione |
|
![XQP XQP](https://data.pdbj.org/pdbjplus/data/cc/svg/XQP.svg) | XQP | Name: | (2R)-2-[(R)-carboxy{[(2R)-2-carboxy-2-(4-hydroxyphenyl)acetyl]amino}methoxymethyl]-5-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,6-dihydro-2H-1,3-oxazine-4-carboxylic acid | Formula: | C20 H22 N6 O10 S | SMILES: | C(O)(C(NC(=O)C(C(=O)O)c1ccc(cc1)O)(C2OCC(=C(C(O)=O)N2)CSc3n(C)nnn3)OC)=O | InChi: | InChI=1S/C20H22N6O10S/c1-26-19(23-24-25-26)37-8-10-7-36-17(21-13(10)16(31)32)20(35-2,18(33)34)22-14(28)12(15(29)30)9-3-5-11(27)6-4-9/h3-6,12,17,21,27H,7-8H2,1-2H3,(H,22,28)(H,29,30)(H,31,32)(H,33,34)/t12-,17-,20-/m1/s1 | Definition date: | 2021-01-04 | Last modified: | 2022-02-04 | Release date: | 2022-02-09 | Identifier: | (2R)-2-[(R)-carboxy{[(2R)-2-carboxy-2-(4-hydroxyphenyl)acetyl]amino}methoxymethyl]-5-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,6-dihydro-2H-1,3-oxazine-4-carboxylic acid |
|
![XSA XSA](https://data.pdbj.org/pdbjplus/data/cc/svg/XSA.svg) | XSA | Name: | (2R)-2-[(2-aminoethyl)amino]-4-boronobutanoic acid | Formula: | C6 H15 B N2 O4 | SMILES: | C(C(O)=O)(NCCN)CCB(O)O | InChi: | InChI=1S/C6H15BN2O4/c8-3-4-9-5(6(10)11)1-2-7(12)13/h5,9,12-13H,1-4,8H2,(H,10,11)/t5-/m1/s1 | Definition date: | 2021-01-08 | Last modified: | 2022-02-04 | Release date: | 2022-02-09 | Identifier: | (2R)-2-[(2-aminoethyl)amino]-4-boronobutanoic acid |
|
![Y5V Y5V](https://data.pdbj.org/pdbjplus/data/cc/svg/Y5V.svg) | Y5V | Name: | 5-hydroxy-N-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-2-(2-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide | Formula: | C21 H21 N3 O5 | SMILES: | c1ccc(c(c1)C2=NC(=C(C(N2)=O)O)C(NCCc3cc(c(cc3)O)OC)=O)C | InChi: | InChI=1S/C21H21N3O5/c1-12-5-3-4-6-14(12)19-23-17(18(26)21(28)24-19)20(27)22-10-9-13-7-8-15(25)16(11-13)29-2/h3-8,11,25-26H,9-10H2,1-2H3,(H,22,27)(H,23,24,28) | Definition date: | 2021-02-05 | Last modified: | 2022-02-04 | Release date: | 2022-02-09 | Identifier: | 5-hydroxy-N-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-2-(2-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide |
|
![Y9Y Y9Y](https://data.pdbj.org/pdbjplus/data/cc/svg/Y9Y.svg) | Y9Y | Name: | paranitrophenyl-alpha-L-galactopyranoside | Formula: | C12 H15 N O8 | SMILES: | OC[CH]1O[CH](Oc2ccc(cc2)[N+]([O-])=O)[CH](O)[CH](O)[CH]1O | InChi: | InChI=1S/C12H15NO8/c14-5-8-9(15)10(16)11(17)12(21-8)20-7-3-1-6(2-4-7)13(18)19/h1-4,8-12,14-17H,5H2/t8-,9+,10+,11-,12+/m0/s1 | Synonyms: | (2~{S},3~{S},4~{R},5~{S},6~{S})-2-(hydroxymethyl)-6-(4-nitrophenoxy)oxane-3,4,5-triol | Definition date: | 2021-02-12 | Last modified: | 2022-02-04 | Release date: | 2022-02-09 | Identifier: | (2~{S},3~{S},4~{R},5~{S},6~{S})-2-(hydroxymethyl)-6-(4-nitrophenoxy)oxane-3,4,5-triol |
|
![R8B R8B](https://data.pdbj.org/pdbjplus/data/cc/svg/R8B.svg) | R8B | Name: | methyl 3-O-((7-carboxy) quinolin-2-yl)-methyl)-beta-D-galactopyranoside | Formula: | C18 H21 N O8 | SMILES: | CO[CH]1O[CH](CO)[CH](O)[CH](OCc2ccc3ccc(cc3n2)C(O)=O)[CH]1O | InChi: | InChI=1S/C18H21NO8/c1-25-18-15(22)16(14(21)13(7-20)27-18)26-8-11-5-4-9-2-3-10(17(23)24)6-12(9)19-11/h2-6,13-16,18,20-22H,7-8H2,1H3,(H,23,24)/t13-,14+,15-,16+,18-/m1/s1 | Synonyms: | 2-[[(2~{R},3~{S},4~{S},5~{R},6~{R})-2-(hydroxymethyl)-6-methoxy-3,5-bis(oxidanyl)oxan-4-yl]oxymethyl]quinoline-7-carboxylic acid | Definition date: | 2020-09-17 | Last modified: | 2022-02-02 | Release date: | 2021-07-28 | Identifier: | 2-[[(2~{R},3~{S},4~{S},5~{R},6~{R})-2-(hydroxymethyl)-6-methoxy-3,5-bis(oxidanyl)oxan-4-yl]oxymethyl]quinoline-7-carboxylic acid |
|
![TAW TAW](https://data.pdbj.org/pdbjplus/data/cc/svg/TAW.svg) | TAW | Name: | Futibatinib | Formula: | C22 H22 N6 O3 | SMILES: | COc1cc(OC)cc(c1)C#Cc2nn([CH]3CCN(C3)C(=O)C=C)c4ncnc(N)c24 | InChi: | InChI=1S/C22H22N6O3/c1-4-19(29)27-8-7-15(12-27)28-22-20(21(23)24-13-25-22)18(26-28)6-5-14-9-16(30-2)11-17(10-14)31-3/h4,9-11,13,15H,1,7-8,12H2,2-3H3,(H2,23,24,25)/t15-/m1/s1 | Synonyms: | TAS-120 | Definition date: | 2020-10-02 | Last modified: | 2022-02-02 | Release date: | 2021-12-22 | Identifier: | 1-[(3~{R})-3-[4-azanyl-3-[2-(3,5-dimethoxyphenyl)ethynyl]pyrazolo[3,4-d]pyrimidin-1-yl]pyrrolidin-1-yl]prop-2-en-1-one |
|
![ZRS ZRS](https://data.pdbj.org/pdbjplus/data/cc/svg/ZRS.svg) | ZRS | Name: | 4-(1H-1,2,4-triazol-1-yl)benzoic acid | Formula: | C9 H7 N3 O2 | SMILES: | O=C(O)c1ccc(cc1)n1cncn1 | InChi: | InChI=1S/C9H7N3O2/c13-9(14)7-1-3-8(4-2-7)12-6-10-5-11-12/h1-6H,(H,13,14) | Definition date: | 2021-05-27 | Last modified: | 2022-01-28 | Release date: | 2022-02-02 | Identifier: | 4-(1H-1,2,4-triazol-1-yl)benzoic acid |
|
![ZGV ZGV](https://data.pdbj.org/pdbjplus/data/cc/svg/ZGV.svg) | ZGV | Name: | 4-[(1E)-3-{[(2E,4E,6E,8S)-8-hydroxy-4-methyldeca-2,4,6-trienoyl]amino}-3-oxoprop-1-en-1-yl]azete-1(2H)-carboxylic acid | Formula: | C18 H22 N2 O5 | SMILES: | OC(=O)N1CC=C1/C=C/C(=O)NC(=O)/C=CC(C)=CC=CC(O)CC | InChi: | InChI=1S/C18H22N2O5/c1-3-15(21)6-4-5-13(2)7-9-16(22)19-17(23)10-8-14-11-12-20(14)18(24)25/h4-11,15,21H,3,12H2,1-2H3,(H,24,25)(H,19,22,23)/b6-4+,9-7+,10-8+,13-5+/t15-/m0/s1 | Definition date: | 2021-04-22 | Last modified: | 2022-01-28 | Release date: | 2022-02-02 | Identifier: | 4-[(1E)-3-{[(2E,4E,6E,8S)-8-hydroxy-4-methyldeca-2,4,6-trienoyl]amino}-3-oxoprop-1-en-1-yl]azete-1(2H)-carboxylic acid |
|
![ZHG ZHG](https://data.pdbj.org/pdbjplus/data/cc/svg/ZHG.svg) | ZHG | Name: | 2,4-bis[(1R)-1-oxidanylethyl]benzene-1,3,5-triol | Formula: | C10 H14 O5 | SMILES: | C[CH](O)c1c(O)cc(O)c([CH](C)O)c1O | InChi: | InChI=1S/C10H14O5/c1-4(11)8-6(13)3-7(14)9(5(2)12)10(8)15/h3-5,11-15H,1-2H3/t4-,5-/m1/s1 | Definition date: | 2021-02-09 | Last modified: | 2022-01-28 | Release date: | 2022-02-02 | Identifier: | 2,4-bis[(1~{R})-1-oxidanylethyl]benzene-1,3,5-triol |
|
![HOR HOR](https://data.pdbj.org/pdbjplus/data/cc/svg/HOR.svg) | HOR | Name: | 4-[[(1R,2R)-2-[(3R)-3-azanylpiperidin-1-yl]-2,3-dihydro-1H-inden-1-yl]oxy]-3-chloranyl-benzenecarbonitrile | Formula: | C21 H22 Cl N3 O | SMILES: | N[CH]1CCCN(C1)[CH]2Cc3ccccc3[CH]2Oc4ccc(cc4Cl)C#N | InChi: | InChI=1S/C21H22ClN3O/c22-18-10-14(12-23)7-8-20(18)26-21-17-6-2-1-4-15(17)11-19(21)25-9-3-5-16(24)13-25/h1-2,4,6-8,10,16,19,21H,3,5,9,11,13,24H2/t16-,19-,21-/m1/s1 | Synonyms: | SAR7334 | Definition date: | 2021-01-25 | Last modified: | 2022-01-28 | Release date: | 2022-02-02 | Identifier: | 4-[[(1~{R},2~{R})-2-[(3~{R})-3-azanylpiperidin-1-yl]-2,3-dihydro-1~{H}-inden-1-yl]oxy]-3-chloranyl-benzenecarbonitrile |
|
![HR3 HR3](https://data.pdbj.org/pdbjplus/data/cc/svg/HR3.svg) | HR3 | Name: | 5-((4-methoxybenzyl)amino)pyridine-2,4-dicarboxylic acid | Formula: | C15 H14 N2 O5 | SMILES: | COc1ccc(CNc2cnc(cc2C(O)=O)C(O)=O)cc1 | InChi: | InChI=1S/C15H14N2O5/c1-22-10-4-2-9(3-5-10)7-16-13-8-17-12(15(20)21)6-11(13)14(18)19/h2-6,8,16H,7H2,1H3,(H,18,19)(H,20,21) | Definition date: | 2021-01-29 | Last modified: | 2022-01-28 | Release date: | 2022-02-02 | Identifier: | 5-[(4-methoxyphenyl)methylamino]pyridine-2,4-dicarboxylic acid |
|
![HR9 HR9](https://data.pdbj.org/pdbjplus/data/cc/svg/HR9.svg) | HR9 | Name: | 5-(4-phenylbutylamino)pyridine-2,4-dicarboxylic acid | Formula: | C17 H18 N2 O4 | SMILES: | OC(=O)c1cc(C(O)=O)c(NCCCCc2ccccc2)cn1 | InChi: | InChI=1S/C17H18N2O4/c20-16(21)13-10-14(17(22)23)19-11-15(13)18-9-5-4-8-12-6-2-1-3-7-12/h1-3,6-7,10-11,18H,4-5,8-9H2,(H,20,21)(H,22,23) | Definition date: | 2021-01-29 | Last modified: | 2022-01-28 | Release date: | 2022-02-02 | Identifier: | 5-(4-phenylbutylamino)pyridine-2,4-dicarboxylic acid |
|
![HRF HRF](https://data.pdbj.org/pdbjplus/data/cc/svg/HRF.svg) | HRF | Name: | 5-(benzylamino)pyridine-2,4-dicarboxylic acid | Formula: | C14 H12 N2 O4 | SMILES: | OC(=O)c1cc(C(O)=O)c(NCc2ccccc2)cn1 | InChi: | InChI=1S/C14H12N2O4/c17-13(18)10-6-11(14(19)20)16-8-12(10)15-7-9-4-2-1-3-5-9/h1-6,8,15H,7H2,(H,17,18)(H,19,20) | Definition date: | 2021-01-29 | Last modified: | 2022-01-28 | Release date: | 2022-02-02 | Identifier: | 5-[(phenylmethyl)amino]pyridine-2,4-dicarboxylic acid |
|
![HRL HRL](https://data.pdbj.org/pdbjplus/data/cc/svg/HRL.svg) | HRL | Name: | 5-((2-methoxybenzyl)amino)pyridine-2,4-dicarboxylic acid | Formula: | C15 H14 N2 O5 | SMILES: | COc1ccccc1CNc2cnc(cc2C(O)=O)C(O)=O | InChi: | InChI=1S/C15H14N2O5/c1-22-13-5-3-2-4-9(13)7-16-12-8-17-11(15(20)21)6-10(12)14(18)19/h2-6,8,16H,7H2,1H3,(H,18,19)(H,20,21) | Definition date: | 2021-01-29 | Last modified: | 2022-01-28 | Release date: | 2022-02-02 | Identifier: | 5-[(2-methoxyphenyl)methylamino]pyridine-2,4-dicarboxylic acid |
|